EMEA-000412-PIP01-08-M01
Key facts
| Invented name |
Levemir
|
| Active substance |
Insulin detemir
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0172/2014
|
| PIP number |
EMEA-000412-PIP01-08-M01
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Novo Nordisk A/S
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-000412-PIP01-08-M01
|
| Compliance opinion date |
14/11/2014
|
| Compliance outcome |
positive
|